Raphael Pharmaceutical RAPH
OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Non-Current Debt (2022 - 2026)

Updated

Raphael Pharmaceutical (RAPH) reported Non-Current Debt of $38,000 for Q4 2023, compared with $3,000 a year earlier.

Analysis

Raphael Pharmaceutical (RAPH) Non-Current Debt (2022 - 2026) Analysis & Trends

  • By year, Non-Current Debt came in at $3,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 Raphael Pharmaceutical 30.47 Mn 30.40 Mn - 1.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.35 Mn
Dec 31, 2025 980,000.00
Dec 31, 2024 456,000.00
Dec 31, 2023 38,000.00
Dec 31, 2022 3,000.00
API Access

Raphael Pharmaceutical Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RAPH&period=max&api_key=YOUR_API_KEY